Patents by Inventor Huiying Wang
Huiying Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230414681Abstract: Bifidobacterium longum strain NCIMB 41676 is useful for improving or sustaining vitality and/or reducing mental fatigue in stressful situations.Type: ApplicationFiled: August 24, 2023Publication date: December 28, 2023Applicant: PrecisionBiotics Group LimitedInventors: Eileen Frances MURPHY, Paul ENCK, Christoph BRAUN, Huiying WANG
-
Patent number: 11771723Abstract: Bifidobacterium longum strain NCIMB 41676 is useful for improving or sustaining vitality and/or reducing mental fatigue in stressful situations.Type: GrantFiled: January 29, 2019Date of Patent: October 3, 2023Assignee: PrecisionBiotics Group LimitedInventors: Eileen Frances Murphy, Paul Enck, Christoph Braun, Huiying Wang
-
Patent number: 10385903Abstract: A metric self-tapping locking screw comprises a screw head which is connected to a thread locking body by a screw rod. The thread locking body and the self-tapping tip are provided with a screw thread on the surface. The self-tapping tip is arranged at the root of the thread locking body; the screw thread adopts the basic structure of the standard ordinary triangular thread. The flank angle back to the fastened surface is 15-20° and the flank angle of the screw thread facing the fastened surface is 30°. The metric self-tapping locking screw in the Invention make the installed parts to be fastened have higher axial clamping force and static loosing moment, which solves the attenuation problem of axial clamping force and static moment of fastened parts.Type: GrantFiled: May 5, 2017Date of Patent: August 20, 2019Assignee: Essence Fastening System (Shanghai) Co., Ltd.Inventors: Qinfeng Yi, Huiying Wang, Xin'an Li
-
Publication number: 20180223889Abstract: A metric self-tapping locking screw comprises a screw head which is connected to a thread locking body by a screw rod. The thread locking body and the self-tapping tip are provided with a screw thread on the surface. The self-tapping tip is arranged at the root of the thread locking body; the screw thread adopts the basic structure of the standard ordinary triangular thread. The flank angle back to the fastened surface is 15-20° and the flank angle of the screw thread facing the fastened surface is 30°. The metric self-tapping locking screw in the Invention make the installed parts to be fastened have higher axial clamping force and static loosing moment, which solves the attenuation problem of axial clamping force and static moment of fastened parts.Type: ApplicationFiled: May 5, 2017Publication date: August 9, 2018Inventors: Qinfeng Yi, Huiying Wang, Xin'an Li
-
Patent number: 8906603Abstract: Compositions, methods and devices for the detection of anti-lipoidal antibodies and the diagnosis of disease, for example, syphilis, are described. In particular, oxidized cardiolipins, which may be conjugated with a variety of attachment molecules, such as BSA, KLH, biotin, synthetic protein MAPS, IgY, streptavidin, or avidin, are described. Such oxidized cardiolipin, alone or complexed with one or more attachment molecules, are useful to detect anti-lipoidal antibodies in subjects, for example, when used in lateral flow devices. Lateral flow devices are described that permit the detection of anti-lipoidal antibodies and that permit the co-detection of nontreponemal and treponemal antibodies in biological samples.Type: GrantFiled: February 14, 2011Date of Patent: December 9, 2014Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and PreventionInventors: Arnold R. Castro, Huiying Wang
-
Publication number: 20140242407Abstract: An in-situ compressed specimen of copper interconnection micro column, which is a circular metal column formed in a PDMS hole, includes: a specimen part and a fixed end part for fixing the specimen; wherein the fixed end part is a circular or square plate structure, the specimen part is an upper part of the fixed end part; a main body of the present invention is of micron order, a forced direction of the specimen is consistent with a growth direction of the metal column. A method of electroplating copper column by adopting PDMS as template substrate is applied to overcome a problem that TSV is corrosive to the copper column during a silicon etching process so as to affect a mechanical property accuracy test, the method is advanced in shortening test process period, achieving good reproducibility and high yield.Type: ApplicationFiled: March 25, 2013Publication date: August 28, 2014Applicant: Shanghai Jiao Tong UniversityInventors: Hong Wang, Zhaoyu Wang, Ping Cheng, Guifu Ding, Ting Gu, Huiying Wang, Congchun Zhang
-
Publication number: 20120064390Abstract: Electrolytes of lithium ion batteries of the present disclosure comprise: a lithium salt, a non-aqueous solvent, and an additive. The additive further comprises a first and second compound. The first compound is a 4 X1, 5 R1 [1,3]dioxolan-2-one, wherein X1 is selected from the group consisting of: F, Cl, and Br and R1 is selected from the group consisting of hydrogen and linear alkyl compounds having between 1 and 3 carbon atoms. The second compound has a molecular formula of: F(CF2CF2)x—CH2CH2—(CH2CH2O)yH, wherein x is any integer ranging from 1 to 7, and y is any integer ranging from 1 to 15.Type: ApplicationFiled: September 9, 2011Publication date: March 15, 2012Inventors: Huiying Wang, Guishu Zhou
-
Publication number: 20110136143Abstract: Compositions, methods and devices for the detection of anti-lipoidal antibodies and the diagnosis of disease, for example, syphilis, are described. In particular, oxidized cardiolipins, which may be conjugated with a variety of attachment molecules, such as BSA, KLH, biotin, synthetic protein MAPS, IgY, streptavidin, or avidin, are described. Such oxidized cardiolipin, alone or complexed with one or more attachment molecules, are useful to detect anti-lipoidal antibodies in subjects, for example, when used in lateral flow devices. Lateral flow devices are described that permit the detection of anti-lipoidal antibodies and that permit the co-detection of nontreponemal and treponemal antibodies in biological samples.Type: ApplicationFiled: February 14, 2011Publication date: June 9, 2011Inventors: Arnold R. Castro, Huiying Wang
-
Patent number: 7888043Abstract: Compositions, methods and devices for the detection of anti-lipoidal antibodies and the diagnosis of disease, for example, syphilis, are described. In particular, oxidized cardiolipins, which may be conjugated with a variety of attachment molecules, such as BSA, KLH, biotin, synthetic protein MAPS, IgY, streptavidin, or avidin, are described. Such oxidized cardiolipin, alone or complexed with one or more attachment molecules, are useful to detect anti-lipoidal antibodies in subjects, for example, when used in lateral flow devices. Lateral flow devices are described that permit the detection of anti-lipoidal antibodies and that permit the co-detection of nontreponemal and treponemal antibodies in biological samples.Type: GrantFiled: November 17, 2006Date of Patent: February 15, 2011Assignee: The United States of America as represented by the Department of Health and Human Services, Centers for Disease Control and PreventionInventors: Arnold R. Castro, Huiying Wang
-
Publication number: 20090253219Abstract: Methods and devices for the detection and/or quantification of an analyte in a sample are provided. These are positive detection methods and devices, in that the more analyte is present in the sample, the stronger the signal that is provided. Devices of the invention include a mobilization zone including a mobile or mobilizable detectable analyte analog, a sample application area, primary and secondary capture areas each including an immobilized binding partner having a binding affinity for the analyte being tested for a detectable analyte analog. The mobilization zone, sample application area, primary and secondary capture area are in fluid continuous contact with each other. In these devices, the first immobilized binding partner has an equal or lower apparent affinity for the analyte than it has for the detectable analyte analog.Type: ApplicationFiled: March 2, 2009Publication date: October 8, 2009Inventors: Jeffrey S. Bauer, Timothy P. Hyatt, Huiying Wang, Robert L. Buck
-
Patent number: 7517699Abstract: Methods and devices for the detection and/or quantification of an analyte in a sample are provided. These are positive detection methods and devices, in that the more analyte is present in the sample, the stronger the signal that is provided. Devices of the invention include a mobilization zone including a mobile or mobilizable detectable analyte analog, a sample application area, primary and secondary capture areas each including an immobilized binding partner having a binding affinity for the analyte being tested for a detectable analyte analog. The mobilization zone, sample application area, primary and secondary capture area are in fluid continuous contact with each other. In these devices, the first immobilized binding partner has an equal or lower apparent affinity for the analyte than it has for the detectable analyte analog.Type: GrantFiled: February 21, 2006Date of Patent: April 14, 2009Assignee: Quantrx Biomedical CorporationInventors: Jeffrey S. Bauer, Timothy P. Hyatt, Huiying Wang, Robert L. Buck
-
Publication number: 20080311597Abstract: Compositions, methods and devices for the detection of anti-lipoidal antibodies and the diagnosis of disease, for example, syphilis, are described. In particular, oxidized cardiolipins, which may be conjugated with a variety of attachment molecules, such as BSA, KLH, biotin, synthetic protein MAPS, IgY, streptavidin, or avidin, are described. Such oxidized cardiolipin, alone or complexed with one or more attachment molecules, are useful to detect anti-lipoidal antibodies in subjects, for example, when used in lateral flow devices. Lateral flow devices are described that permit the detection of anti-lipoidal antibodies and that permit the co-detection of nontreponemal and treponemal antibodies in biological samples.Type: ApplicationFiled: November 17, 2006Publication date: December 18, 2008Inventors: Arnold R. Castro, Huiying Wang
-
Publication number: 20060141639Abstract: Methods and devices for the detection and/or quantification of an analyte in a sample are provided. These are positive detection methods and devices, in that the more analyte is present in the sample, the stronger the signal that is provided. Devices of the invention include a mobilization zone including a mobile or mobilizable detectable analyte analog, a sample application area, primary and secondary capture areas each including an immobilized binding partner having a binding affinity for the analyte being tested for a detectable analyte analog. The mobilization zone, sample application area, primary and secondary capture area are in fluid continuous contact with each other. In these devices, the first immobilized binding partner has an equal or lower apparent affinity for the analyte than it has for the detectable analyte analog.Type: ApplicationFiled: February 21, 2006Publication date: June 29, 2006Inventors: Jeffrey Bauer, Timothy Hyatt, Huiying Wang, Robert Buck
-
Patent number: 6699722Abstract: Methods and devices for the detection and/or quantification of an analyte in a sample are provided. These are positive detection methods and devices, in that the more analyte is present in the sample, the stronger the signal that is provided. Devices of the invention include a mobilization zone including a mobile or mobilizable detectable analyte analog, a sample application area, primary and secondary capture areas each including an immobilized binding partner having a binding affinity for the analyte being tested for a detectable analyte analog. The mobilization zone, sample application area, primary and secondary capture area are in fluid continuous contact with each other. In these devices, the first immobilized binding partner has an equal or lower apparent affinity for the analyte than it has for the detectable analyte analog.Type: GrantFiled: April 13, 2001Date of Patent: March 2, 2004Assignee: A-Fem Medical CorporationInventors: Jeffrey S. Bauer, Timothy P. Hyatt, Huiying Wang
-
Publication number: 20020142291Abstract: Methods and devices for the detection and/or quantification of an analyte in a sample are provided. These are positive detection methods and devices, in that the more analyte is present in the sample, the stronger the signal that is provided. Devices of the invention include a mobilization zone including a mobile or mobilizable detectable analyte analog, a sample application area, primary and secondary capture areas each including an immobilized binding partner having a binding affinity for the analyte being tested for a detectable analyte analog. The mobilization zone, sample application area, primary and secondary capture area are in fluid continuous contact with each other. In these devices, the first immobilized binding partner has an equal or lower apparent affinity for the analyte than it has for the detectable analyte analog.Type: ApplicationFiled: April 13, 2001Publication date: October 3, 2002Inventors: Jeffrey S. Bauer, Timothy P. Hyatt, Huiying Wang
-
Patent number: 6306665Abstract: Microporous solid phase materials that are suitable for lateral flow and other assays for detecting the presence of analytes in test samples, that are stable under variations in humidity and, even after storage for extended periods of time, can form stable covalent bonds with molecules containing a free primary or secondary amine group or sulfhydryl group are described. The invention further concerns chemically derivatized solid phase materials, and conjugates comprising such materials. Examples of lateral flow devices for the quantitative or semi-quantitative determination of an analyte in a biological sample are described.Type: GrantFiled: October 13, 1999Date of Patent: October 23, 2001Assignee: A-Fem Medical CorporationInventors: Robert Lee Buck, Huiying Wang, Timothy Patrick Hyatt, Paul Andrew Mueggler